List of Tables
Table 1. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (2020-2025) & (K Units)
Table 8. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Alzheimer's Disease (AD) Blood-based Detection Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease (AD) Blood-based Detection Kits as of 2024)
Table 16. Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Manufacturing Base and Headquarters
Table 19. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Type (2020-2025) & (K Units)
Table 23. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Type (2026-2031) & (K Units)
Table 24. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Alzheimer's Disease (AD) Blood-based Detection Kits ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Application (2020-2025) & (K Units)
Table 29. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Application (2026-2031) & (K Units)
Table 30. Alzheimer's Disease (AD) Blood-based Detection Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Alzheimer's Disease (AD) Blood-based Detection Kits ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Alzheimer's Disease (AD) Blood-based Detection Kits Growth Accelerators and Market Barriers
Table 37. North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Growth Accelerators and Market Barriers
Table 40. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Investment Opportunities and Key Challenges
Table 47. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Roche Diagnostics Corporation Information
Table 51. Roche Diagnostics Description and Major Businesses
Table 52. Roche Diagnostics Product Models, Descriptions and Specifications
Table 53. Roche Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Roche Diagnostics Sales Value Proportion by Product in 2024
Table 55. Roche Diagnostics Sales Value Proportion by Application in 2024
Table 56. Roche Diagnostics Sales Value Proportion by Geographic Area in 2024
Table 57. Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits SWOT Analysis
Table 58. Roche Diagnostics Recent Developments
Table 59. Fujirebio Corporation Information
Table 60. Fujirebio Description and Major Businesses
Table 61. Fujirebio Product Models, Descriptions and Specifications
Table 62. Fujirebio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Fujirebio Sales Value Proportion by Product in 2024
Table 64. Fujirebio Sales Value Proportion by Application in 2024
Table 65. Fujirebio Sales Value Proportion by Geographic Area in 2024
Table 66. Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits SWOT Analysis
Table 67. Fujirebio Recent Developments
Table 68. Quanterix Corporation Information
Table 69. Quanterix Description and Major Businesses
Table 70. Quanterix Product Models, Descriptions and Specifications
Table 71. Quanterix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Quanterix Sales Value Proportion by Product in 2024
Table 73. Quanterix Sales Value Proportion by Application in 2024
Table 74. Quanterix Sales Value Proportion by Geographic Area in 2024
Table 75. Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits SWOT Analysis
Table 76. Quanterix Recent Developments
Table 77. Revvity Corporation Information
Table 78. Revvity Description and Major Businesses
Table 79. Revvity Product Models, Descriptions and Specifications
Table 80. Revvity Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Revvity Sales Value Proportion by Product in 2024
Table 82. Revvity Sales Value Proportion by Application in 2024
Table 83. Revvity Sales Value Proportion by Geographic Area in 2024
Table 84. Revvity Alzheimer's Disease (AD) Blood-based Detection Kits SWOT Analysis
Table 85. Revvity Recent Developments
Table 86. People Bio Corporation Information
Table 87. People Bio Description and Major Businesses
Table 88. People Bio Product Models, Descriptions and Specifications
Table 89. People Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. People Bio Sales Value Proportion by Product in 2024
Table 91. People Bio Sales Value Proportion by Application in 2024
Table 92. People Bio Sales Value Proportion by Geographic Area in 2024
Table 93. People Bio Alzheimer's Disease (AD) Blood-based Detection Kits SWOT Analysis
Table 94. People Bio Recent Developments
Table 95. Easund Bio-tech and Pharmakea Corporation Information
Table 96. Easund Bio-tech and Pharmakea Description and Major Businesses
Table 97. Easund Bio-tech and Pharmakea Product Models, Descriptions and Specifications
Table 98. Easund Bio-tech and Pharmakea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Easund Bio-tech and Pharmakea Recent Developments
Table 100. MagQu Corporation Information
Table 101. MagQu Description and Major Businesses
Table 102. MagQu Product Models, Descriptions and Specifications
Table 103. MagQu Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. MagQu Recent Developments
Table 105. Solgent Corporation Information
Table 106. Solgent Description and Major Businesses
Table 107. Solgent Product Models, Descriptions and Specifications
Table 108. Solgent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Solgent Recent Developments
Table 110. Sysmex Corporation Information
Table 111. Sysmex Description and Major Businesses
Table 112. Sysmex Product Models, Descriptions and Specifications
Table 113. Sysmex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Sysmex Recent Developments
Table 115. Fujifilm Corporation Information
Table 116. Fujifilm Description and Major Businesses
Table 117. Fujifilm Product Models, Descriptions and Specifications
Table 118. Fujifilm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Fujifilm Recent Developments
Table 120. Immuno-Biological Laboratories Corporation Information
Table 121. Immuno-Biological Laboratories Description and Major Businesses
Table 122. Immuno-Biological Laboratories Product Models, Descriptions and Specifications
Table 123. Immuno-Biological Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Immuno-Biological Laboratories Recent Developments
Table 125. Shenzhen Anqun Bioengineering Corporation Information
Table 126. Shenzhen Anqun Bioengineering Description and Major Businesses
Table 127. Shenzhen Anqun Bioengineering Product Models, Descriptions and Specifications
Table 128. Shenzhen Anqun Bioengineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Shenzhen Anqun Bioengineering Recent Developments
Table 130. Amoneta Diagnostics Corporation Information
Table 131. Amoneta Diagnostics Description and Major Businesses
Table 132. Amoneta Diagnostics Product Models, Descriptions and Specifications
Table 133. Amoneta Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Amoneta Diagnostics Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer's Disease (AD) Blood-based Detection Kits Product Picture
Figure 2. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Amyloid Beta (Aβ) Detection Kits Product Picture
Figure 4. Tau Protein Detection Kits Product Picture
Figure 5. Others Product Picture
Figure 6. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Medical
Figure 8. Research
Figure 9. Alzheimer's Disease (AD) Blood-based Detection Kits Report Years Considered
Figure 10. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 12. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Region (2020-2031)
Figure 14. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (2020-2031) & (K Units)
Figure 15. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume Market Share in 2024
Figure 18. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Amyloid Beta (Aβ) Detection Kits Revenue Market Share by Manufacturer in 2024
Figure 21. Tau Protein Detection Kits Revenue Market Share by Manufacturer in 2024
Figure 22. Others Revenue Market Share by Manufacturer in 2024
Figure 23. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Type (2020-2031)
Figure 24. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Type (2020-2031)
Figure 25. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Application (2020-2031)
Figure 26. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Application (2020-2031)
Figure 27. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales YoY (2020-2031) & (K Units)
Figure 28. North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) in 2024
Figure 30. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) in 2024
Figure 40. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 45. France Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 60. India Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (2020-2025) & (US$ Million)
Figure 81. Alzheimer's Disease (AD) Blood-based Detection Kits Industry Chain Mapping
Figure 82. Regional Alzheimer's Disease (AD) Blood-based Detection Kits Manufacturing Base Distribution (%)
Figure 83. Global Alzheimer's Disease (AD) Blood-based Detection Kits Production Market Share by Region (2020-2031)
Figure 84. Alzheimer's Disease (AD) Blood-based Detection Kits Production Process
Figure 85. Regional Alzheimer's Disease (AD) Blood-based Detection Kits Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed